Wegovy Vomiting: How Common, How Long It Lasts, What Helps
Yes. In the Wegovy trials, 36% of people on 2.4 mg had vomiting, against 10% on placebo: about 4 times the placebo rate. Smaller, slower meals help most.
- In the Wegovy label
- Yes, with a rate
- On Wegovy 2.4 mg
- 36%
- On placebo
- 10%
A quick Wegovy overview
Its half-life is about 1 week: after 7 d, half is gone, and five half-lives (35 d) leave about 3%
Across STEP 1's 68 weeks, 14.9% of body weight was lost, versus 2.4% with placebo.
Monthly prices in US dollars include the list price and self-pay offers, each taken from the maker's price page
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
Wegovy vs placebo: how often it occurs
The label trials report Wegovy vomiting by dose group A placebo is the comparison group in the same trial.
| Medicine and dose | Vomiting | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Wegovy 2.4 mg | 24% | 6% | +18 points | Adults with obesity or overweight (weight management) |
| Wegovy 2.4 mg | 16% | 6% | +10 points | Adults with obesity (7.2 mg dose trials) |
| Wegovy 7.2 mg | 22% | 6% | +16 points | Adults with obesity (7.2 mg dose trials) |
| Wegovy 2.4 mg | 36% | 10% | +26 points | Children 12 and older with obesity |
Source for these details: Wegovy label (DailyMed)
Other GLP-1s: Vomiting Compared with Wegovy
Every label describes its own trials, which included different groups of people Consider it a rough guide
The pill forms shown in the table are Rybelsus and Foundayo
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| 24% | 2.4 mg | 6% | Adults with obesity or overweight (weight management) | |
| 24% | 17.2 mg | 4% | Adults with obesity or overweight (weight management) | |
| 15.7% | all doses | 3.9% | Adults with obesity or overweight (weight management) | |
| 13% | 15 mg | 2% | Adults with obesity or overweight (weight management) | |
| Byetta | 13% | all doses | 4% | Adults with type 2 diabetes |
| 12.7% | 1.5 mg | 2.3% | Adults with type 2 diabetes | |
| 9.2% | 1 mg | 2.3% | Adults with type 2 diabetes | |
| 9% | 15 mg | 2% | Adults with type 2 diabetes | |
| 9% | 1.8 mg | 2% | Adults with type 2 diabetes | |
| 8% | 14 mg | 3% | Adults with type 2 diabetes |
Sources listed: Ozempic label (DailyMed), Wegovy label (DailyMed), Rybelsus label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed)
Source: FDA label (DailyMed).
Why this happens while you are taking Wegovy
How fast the stomach empties slows down with these medicines. Because food stays in your stomach longer, vomiting can occur, especially after big or fatty meals
Source: health.clevelandclinic.org.
What the Wegovy label says
Here, the label mentions vomiting word for word:
“most common adverse reactions leading to discontinuation were nausea (1.8% versus 0.2%), vomiting (1.2% versus 0%), and diarrhea (0.7% versus 0.1%) for WEGOVY and placebo,”
Source: FDA label (DailyMed).
What helps, step by step
- Drink water in small amounts often so you do not get dehydrated.
- After you eat, stay upright rather than lie down.
- Ask your prescriber about a nausea medicine you can keep on hand.
- Choose smaller meals and stop eating once you feel full. These medicines slow down how quickly your stomach empties.
- Eat slowly. Your brain needs time to recognize that you feel full.
- Fatty, greasy, and sugary foods often cause symptoms, so limit how much you eat.
- If symptoms fail to ease, tell your prescriber. Your prescriber may slow how quickly doses increase, or suggest a different GLP-1 medicine.
Before taking anything from the drugstore, use the GLP-1 interaction checker to check it.
Source: health.clevelandclinic.org.